trending Market Intelligence /marketintelligence/en/news-insights/trending/if3f46ffnuRTcoRMqca7YQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Veloxis Pharmaceuticals appoints chief commercial officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Veloxis Pharmaceuticals appoints chief commercial officer

Veloxis Pharmaceuticals A/S promoted Mark Hensley to the role of chief commercial officer.

Hensley has been serving as the company's vice president of sales since May 2017. He also held different senior leadership roles in Chiesi USA Inc. and Cornerstone Therapeutics Inc. before joining Veloxis.

Copenhagen-based Veloxis Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes products used in transplant procedures and adjacent therapies.